1. (a) Unless excused from reporting under AS 17.30.200(t), a pharmacist-in-charge must submit information on behalf of the employing pharmacy required under AS 17.30.200(b) and other information required by the American Society of Automation in Pharmacy (ASAP), as specified in the Appriss Health, PMP AWARxE Data Submission Guide for Dispensers, Alaska Prescription Drug Monitoring Program, Version 2.2, April 2021, adopted by reference. If the pharmacist-in-charge is not present, a pharmacist or third-party vendor may report on behalf of the pharmacy. A practitioner, practitioner's delegate, or third-party vendor may also report on behalf of the practitioner.
2. (b) Unless excused from reporting under AS 17.30.200(t), a pharmacist or practitioner required to submit information under AS 17.30.200(b) must submit the information to the PDMP daily. Information regarding a schedule II, III, or IV controlled substance prescribed by a veterinarian and dispensed by a pharmacist must be submitted by the pharmacist. Nothing affects the inapplicability of this section to veterinarians under AS 17.30.200(u).
3. (c) If the pharmacist or practitioner did not dispense any Schedule II, III, or IV controlled substances on the previous day, the pharmacist or practitioner must submit a zero report.
4. (d) The time computation under 12 AAC 02.920(b) applies to a submission of information under AS 17.30.200(b) and this section.
5. (e) For the purposes of AS 17.30.200(b)(1), "other appropriate identifier" and for the purposes of 17.30.200(b)(8), "other appropriate identifying information" mean the state-issued license number of the prescribing practitioner and state-issued license number of the dispensing pharmacist or practitioner.
6. (f) Not later than 72 hours after discovering an error in information submitted under AS 17.30.200(b), a pharmacist or practitioner required to submit the information under AS 17.30.200(b) must notify the PDMP administrator. The time computation under 12 AAC 02.920(b) applies to a submission of information correcting an error in information submitted under AS 17.30.200(b).
7. (g) Unless excused from reporting under AS 17.30.200(t), or a waiver is granted under 12 AAC 52.870, a pharmacist or practitioner required to submit information under AS 17.30.200(b) must submit the information to the PDMP electronically through the website provided by the board.
8. (h) Unless excused from reviewing the PDMP under AS 17.30.200(k)(4)(A) - (B), a practitioner, but not a pharmacist, must review the information in the PDMP to check a patient's prescription records before dispensing, prescribing, or administering a schedule II or III controlled substance under federal law.

(Eff. 12/29/2011, Register 200; am 6/7/2018, Register 226; am 12/28/2022, Register 244; am 1/19/2024, Register 249)